Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
<p>Background</p> Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel...
Auteurs principaux: | Salman, R, Minks, DP, Mitra, D, Rodrigues, MA, Bhatnagar, P, Du Plessis, JC, Joshi, Y, Dennis, MS, Murray, GD, Newby, DE, Sandercock, PAG, Sprigg, N, Stephen, J, Sudlow, CLM, Werring, DJ, Whiteley, WN, Wardlaw, JM, White, PM, Restart Collaboration, Armitage, J |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2019
|
Documents similaires
-
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
par: Salman, R, et autres
Publié: (2018) -
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
par: Baigent, C, et autres
Publié: (2019) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
par: Rustam Al-Shahi Salman, et autres
Publié: (2018-03-01) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
par: Rustam Al-Shahi Salman, et autres
Publié: (2019-03-01) -
Cerebral Amyloid Angiopathy and Intracerebral Haemorrhage
par: David Werring, et autres
Publié: (2016-09-01)